• Flash proton radiotherapy spares normal epithelial and mesenchymal tissues while preserving sarcoma response 

      Velalopoulou A., Karagounis I.V., Cramer G.M., Kim M.M., Skoufos G., Goia D., Hagan S., Verginadis I.I., Shoniyozov K., Chiango J., Cerullo M., Varner K., Yao L., Qin L., Hatzigeorgiou A.G., Minn A.J., Putt M., Lanza M., Assenmacher C.-A., Radaelli E., Huck J., Diffenderfer E., Dong L., Metz J., Koumenis C., Cengel K.A., Maity A., Busch T.M. (2021)
      In studies of electron and proton radiotherapy, ultrahigh dose rates of FLASH radiotherapy appear to produce fewer toxicities than standard dose rates while maintaining local tumor control. FLASHproton radiotherapy (F-PRT) ...
    • Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network across Rural Greece: The Grecoself study 

      Agorastos T., Chatzistamatiou K., Tsertanidou A., Mouchtaropoulou E., Pasentsis K., Kitsou A., Moysiadis T., Moschaki V., Skenderi A., Katsiki E., Aggelidou S., Venizelos I., Ntoula M., Daponte A., Vanakara P., Garas A., Stefos T., Vrekoussis T., Lymberis V., Kontomanolis E.N., Makrigiannakis A., Manidakis G., Deligeoroglou E., Panoskaltsis T., Decavalas G.O., Michail G., Kalogiannidis I., Koukoulis G., Zempili P., Halatsi D., Truva T., Piha V., Agelena G., Chronopoulou A., Vaitsi V., Chatzaki E., Paschopoulos M., Adonakis G., Kaufmann A.M., Hadzidimitriou A., Stamatopoulos K. (2019)
      Self-sampling for human papillomavirus (HPV) testing is an alternative to physician sampling particularly for cervical cancer screening nonattenders. The GRECOSELF study is a nationwide observational cross-sectional study ...
    • Survivin autoantibodies are not elevated in lung cancer when assayed controlling for specificity and smoking status 

      Broodman I., VanDuijn M.M., Stingl C., Dekker L.J.M., Germenis A.E., De Koning H.J., Van Klaveren R.J., Aerts J.G., Lindemans J., Luider T.M. (2016)
      The high mortality rate in lung cancer is largely attributable to late diagnosis. Case-control studies suggest that autoantibodies to the survivin protein are potential biomarkers for early diagnosis. We tested the hypothesis ...